The company was founded exclusively by Changchun High-tech Industry Development Corporation, with a total share capital of 137.5 million shares. In the more than 20 years since the company was listed, Changchun Hi-Tech has successfully transformed from when the company was founded, focusing on infrastructure construction in the high-tech zone, to become an enterprise group focusing on the field of pharmaceutical science and technology innovation and implementing industrial investment. The company's main business is R&D, production and sales of biopharmaceuticals and proprietary Chinese medicines, as well as real estate development, property management, and services. The main products are growth hormone series products, follicle-stimulating hormones, nutritional supplements for children; live attenuated chickenpox vaccine, live attenuated vaccine for shingles; live attenuated vaccine for shingles; silver flower anti-inflammatory tablets, thromboventricular tablets, stomach cleansing and pain relief pellets, etc.; Gaoxin Yizhong Famous City, Gaoxin Heyuan, Gaoxin Huiyuan, Gaoxin Junyuan, Gaoxin Rongyuan, etc. The company received the most respected listed company for investment in 2017, academician and expert workstation certification, honors such as famous brand products in Jilin Province in 2012, and the top 100 enterprises in China's pharmaceutical manufacturing industry.
No Data